Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Shlaifer, Irina  [Clear All Filters]
2024
Dorion M-F, Casas D, Shlaifer I, Yaqubi M, Fleming P, Karpilovsky N, Chen CX-Q, Nicouleau M, Piscopo VEC, MacDougall EJ, et al. An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders. Mol Neurodegener. 2024;19(1):31.
2023
Dorion M-F, Yaqubi M, Senkevich K, Kieran NW, MacDonald A, Chen CX-Q, Luo W, Wallis A, Shlaifer I, Hall JA, et al. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Brain. 2023.
2022
Chen CX-Q, You Z, Abdian N, Sirois J, Shlaifer I, Tabatabaei M, Boivin M-N, Gaborieau L, Karamchandani J, Beitel LK, et al. Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing. Stem Cell Res. 2022;62:102806.
Chen CX-Q, Deneault E, Abdian N, You Z, Sirois J, Nicouleau M, Shlaifer I, Villegas L, Boivin M-N, Gaborieau L, et al. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson's associated GBA gene. Stem Cell Res. 2022;64:102919.
2021
Deneault E, Chaineau M, Nicouleau M, Montiel MJosé Cast, Flores AKristyna F, Haghi G, Chen CX-Q, Abdian N, Shlaifer I, Beitel LK, et al. A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis. Methods. 2021.